These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 30376220)
1. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls. Russell-Goldman E; Hornick JL; Qian X; Jo VY Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Hung YP; Fletcher CD; Hornick JL Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175 [TBL] [Abstract][Full Text] [Related]
3. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. McCuiston A; Bishop JA Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785 [TBL] [Abstract][Full Text] [Related]
5. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013 [TBL] [Abstract][Full Text] [Related]
6. Correlation NKX2.2 IHC and Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211 [TBL] [Abstract][Full Text] [Related]
7. Primary pancreatic Ewing sarcoma: a cytomorphologic and histopathologic study of 13 cases. Miller DL; Roy-Chowdhuri S; Illei P; James A; Hruban RH; Ali SZ J Am Soc Cytopathol; 2020; 9(6):502-512. PubMed ID: 32536453 [TBL] [Abstract][Full Text] [Related]
8. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943 [TBL] [Abstract][Full Text] [Related]
9. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma. Rooper LM; Sharma R; Gocke CD; Belchis DA Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015 [TBL] [Abstract][Full Text] [Related]
10. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors. Chebib I; Jo VY Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Hung YP; Fletcher CD; Hornick JL Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513 [TBL] [Abstract][Full Text] [Related]
13. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993 [TBL] [Abstract][Full Text] [Related]
14. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors. Halliday BE; Slagel DD; Elsheikh TE; Silverman JF Diagn Cytopathol; 1998 Dec; 19(6):410-6. PubMed ID: 9839129 [TBL] [Abstract][Full Text] [Related]
16. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study. Syed M; Mushtaq S; Loya A; Hassan U Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222 [TBL] [Abstract][Full Text] [Related]
17. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls-Comment on Russell-Goldman et al. Creytens D Cancer Cytopathol; 2019 Mar; 127(3):202. PubMed ID: 30720925 [No Abstract] [Full Text] [Related]
18. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours. Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735 [TBL] [Abstract][Full Text] [Related]
19. A case report of CIC-rearranged undifferentiated small round cell sarcoma in the cerebrum. Ito M; Ishikawa M; Kitajima M; Narita J; Hattori S; Endo O; Goto K Diagn Cytopathol; 2016 Oct; 44(10):828-32. PubMed ID: 27324529 [TBL] [Abstract][Full Text] [Related]
20. Ewing sarcoma and Ewing-like tumors. Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]